For laboratory research use only. Not for human consumption.

Free U.S. shipping on $200+
GLPZonePeptides for laboratory research
0

GLPZone / The research collection

GLPZone CJC-IPAMORELIN Blend, 10 MG vial
Illustrative certificateNS-2026-06044

Nordicstar Analytical Sciences

CJC-IPAMORELIN Blend 10 MG

99.589%HPLC purity
Lot
GLZ-26-CJCIPA-1043
Measured content
10.03 mg
Mass-spec identity
Confirmed
Endotoxin
<1.0 EU/mg
Tested
14 Sep 2026
View Lab Report
Lyophilized

Repair & Recovery

CJC-IPAMORELIN Blend

GHRH & GHS-R1a pathway research

$84.00USD / vialView COA

A pair saves 10%. A set of three saves 15%.

Strength 10 MG
Vial quantity
  • Complimentary priority shipping from $200
  • Dispatched within 1–2 business days
  • Compare strengths and prices before ordering

For laboratory research use only.
Not for human consumption or clinical use.

Compound details
Compound
CJC-IPAMORELIN Blend
Form
Lyophilized
Quality & documentation

The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.

Lot
GLZ-26-CJCIPA-1043
HPLC purity
99.589%
Measured content
10.03 mg
Tested
14 Sep 2026
Report
NS-2026-06044
View the 10 MG certificate
Our quality approach
Shipping & handling

Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.

Shipping information
Explore the research profile
CJC-IPAMORELIN Blend10 MG · Single
$84.00

01 / The compound

Understand
the starting point.

GHRH & GHS-R1a pathway research

CJC-1295 / Ipamorelin Blend combines two research peptides associated with distinct signaling pathways studied in growth hormone research. CJC-1295 belongs to the growth hormone-releasing hormone (GHRH) analogue class, while Ipamorelin is a growth hormone secretagogue studied through the GHS receptor pathway.

The pairing provides a single research preparation for investigating these two signaling pathways within the same experimental framework.

Published research on CJC-1295 requires careful interpretation because different forms have been studied and described under related naming conventions. The specific DAC or non-DAC form of the CJC-1295 component in this blend has not been verified in the available product documentation, so form-specific characteristics are not assigned to this product.

02 / Research profile

The pathways.
The possibilities.

CJC-1295 and Ipamorelin are associated with different receptor pathways involved in growth-hormone signaling.

GHRH analogues are investigated through the GHRH receptor pathway, while Ipamorelin belongs to a class of growth-hormone secretagogues associated with GHS-R1a.

The research rationale for examining the two compounds within the same experimental system comes from this distinction between receptor pathways. Studying both pathways together can help researchers investigate receptor interaction and downstream signaling under controlled laboratory conditions.

Direct research on this exact CJC-1295 / Ipamorelin combination is limited, so findings from either component individually should not automatically be assigned to the combined preparation.

01 / Research focus

Ipamorelin Research

Ipamorelin has been characterized in preclinical research involving growth-hormone secretagogue pharmacology, receptor selectivity and GHS-R1a-associated signaling. Animal studies have also examined Ipamorelin in skeletal and gastrointestinal research models, including bone-formation and postoperative intestinal-motility experiments. These studies provide research context for Ipamorelin as an individual compound and do not establish the behavior of the CJC-1295 / Ipamorelin blend.

02 / Research focus

CJC-1295 Research

CJC-1295-related research has examined GHRH-receptor activation, albumin-binding molecular design and peptide persistence in experimental models. A foundational preclinical study characterized albumin-linked hGRF(1-29) bioconjugates and identified CJC-1295 as a long-lasting GHRH-related analogue in a rat model. Because the exact DAC or No-DAC form of the CJC-1295 component in this blend has not been established from the available product documentation, form-specific characteristics should not be assigned to this product.

03 / Research focus

Research on the Two Pathways Together

The scientific rationale for studying GHRH-receptor signaling and growth-hormone-secretagogue signaling within the same experimental framework comes from their interaction with distinct receptor systems. This provides a mechanistic basis for investigating pathway interaction, but it does not establish that this exact CJC-1295 / Ipamorelin preparation has demonstrated a specific combined biological effect.

Reading the evidence

No direct primary study evaluating CJC-1295 and Ipamorelin together as the exact combination shown in this summary is included in the source literature. The available evidence therefore comes from research on the individual compounds and their respective receptor pathways. Those findings should not be presented as direct evidence that this exact blend produces a particular combined biological response.

03 / Reference data

The details,
in plain sight.

Reference specifications describe a compound. The final lot documentation identifies the material supplied.

CJC-IPAMORELIN Blend reference specifications
CompoundCJC-IPAMORELIN Blend
Research areaRepair & Recovery
Physical formLyophilized
Vial options10 MG
Intended useLaboratory research only

Variant amounts are nominal catalog quantities. They are not instructions for use.

04 / Quality & documentation

A number needs
its context.

How testing works
01 / Purity

What is in the sample?

HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.

02 / Identity

Is it the expected compound?

Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.

03 / Traceability

Does the report match the vial?

Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.

Independent analysis

Every CJC-IPAMORELIN Blend lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.

Read a COA with confidence
CJC-IPAMORELIN Blend lot certificates
PresentationLotHPLC purityTestedCertificate
10 MG Current lotGLZ-26-CJCIPA-104399.589%14 Sep 2026NS-2026-06044

05 / Storage & handling

Care for
the material.

Keep sealed research material protected from moisture, unnecessary light and temperature fluctuations. Use the storage conditions documented for the specific compound, formulation and lot.

Solution stability depends on solvent, concentration, container and experimental conditions. Use a validated laboratory protocol; a universal post-reconstitution shelf life is not established by the literature summaries.

Explore the handling guide

06 / Common questions

A little more
understanding.

What is CJC-1295 / Ipamorelin Blend?

CJC-1295 / Ipamorelin Blend combines a peptide from the GHRH analogue class with Ipamorelin, a growth hormone secretagogue. The two compounds are associated with distinct signaling pathways studied in growth hormone research.

Do CJC-1295 and Ipamorelin act through the same research pathway?

No. CJC-1295 belongs to the GHRH analogue class, while Ipamorelin is studied as a growth hormone secretagogue. Their association with different receptor pathways is part of the scientific rationale for investigating the compounds together.

Has CJC-1295 / Ipamorelin been directly studied as a combination?

No direct primary study evaluating CJC-1295 and Ipamorelin together as the exact combination is included in the source literature. Research exists for the individual compounds, while separate studies involving GHRH and other growth hormone-releasing peptides provide related evidence about the interaction between these broader signaling pathways.

Is the CJC-1295 component in this blend DAC or No DAC?

The available product documentation does not establish a DAC or non-DAC designation for the CJC-1295 component. Form-specific persistence cannot be assigned without further identity documentation.

07 / Further reading

Go to
the source.

Selected literature for context. Read each study’s methods, experimental model, and limitations alongside its findings.

  1. 01
  2. 02
  3. 03
Our approach to research content

Curated pairings

Often studied together.

Explore the collection

Your research collection

Your bag 0

A new perspective awaits

Your bag is empty.

Explore the collection and find the compounds for your next research question.

Explore compounds

Find a research compound

Try GLP-3-RT, BPC-157, or NAD+.